Enimmune corporation Reports Earnings Results for the Full Year Ended December 31, 2021
April 26, 2022 at 04:30 am EDT
Enimmune corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 109.82 million compared to TWD 22.88 million a year ago. Net loss was TWD 47.25 million compared to TWD 74.45 million a year ago. Basic loss per share from continuing operations was TWD 0.79 compared to TWD 1.4 a year ago. Diluted loss per share from continuing operations was TWD 0.79 compared to TWD 1.4 a year ago.